SCHAUMBURG, Ill., Oct. 20 /PRNewswire-FirstCall/ -- American Pharmaceutical Partners, Inc. announced today that it will release its 2005 third quarter financial results before the market opens on Tuesday, November 1, 2005. The company also said that senior management will host an investor conference call that same day at 10:00 a.m. Eastern to review the company’s financial results and operations.
The conference call will be available to interested parties through a live audio Internet broadcast at www.appdrugs.com and www.earnings.com. The call will also be archived and accessible at both sites for one year.
About American Pharmaceutical Partners, Inc.
American Pharmaceutical Partners, Inc. is a specialty drug company that develops, manufactures and markets injectable pharmaceutical products, focusing on the oncology, anti-infective and critical care markets. Abraxis Oncology, the proprietary division of APP, is devoted entirely to developing and promoting innovative, next-generation cancer therapies such as ABRAXANE(TM), recently launched for the treatment of metastatic breast cancer. For more information, visit APP’s website at www.appdrugs.com and www.abraxisoncology.com.
Contacts: American Pharmaceutical Partners, Inc. Nicole Williams Executive Vice President & CFO (847) 969-2700 Rob Whetstone/Robert Jaffe PondelWilkinson Inc. (310) 279-5963
American Pharmaceutical Partners, Inc.
CONTACT: Nicole Williams, Executive Vice President & CFO of AmericanPharmaceutical Partners, Inc., +1-847-969-2700; or Rob Whetstone, or RobertJaffe, both of PondelWilkinson Inc., +1-310-279-5963, for AmericanPharmaceutical Partners, Inc.
